We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pfizer, Merck to Evaluate Novel Anti-Cancer Combination Regimen

News   Aug 27, 2014

 
Pfizer, Merck to Evaluate Novel Anti-Cancer Combination Regimen
 
 
 

RELATED ARTICLES

Injecting Dying Cells to Trigger Tumor Destruction

News

By directly injecting engineered dying cells into tumors, researchers have successfully triggered the immune system to attack the cancerous cells at multiple sites within the body and reduce tumor growth, in mice.

READ MORE

Cancer Control: Researchers Solve the Structure of Important Transport Protein

News

Scientists have published the first structure of a lactate-transporter of the SLC16-family (SfMCT) that may have therapeutic benefit in cancer.

READ MORE

Biomedical Bleeding May Impact Horseshoe Crab Spawning Behavior

News

Horseshoe crabs that have undergone biomedical bleeding tend to reside in deeper water and approach mating beaches less often, suggesting the reproductive output of female horseshoe crabs may be compromised during the season in which they were bled.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE